GlassScriptPhysician profile
Brian Solomon
NPI 1487827531
$76,220.47
in general payments reported to CMS, 2019-2025
28 companies · $17K in 2025
The $17K reported for 2025 was more than what 93% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $23K · 2021: $2,144 · 2022: $705 · 2023: $1,018 · 2024: $20K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $30K · Food and Beverage: $6,279 · Travel and Lodging: $3,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $29,505.05 |
| Food and Beverage | $6,278.69 |
| Travel and Lodging | $3,000.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $31,662.22 | 2019-2023 | Da Vinci Surgical System |
| Baxter Healthcare | $30,907.84 | 2021-2025 | Coseal, Hemopatch, Floseal |
| Abiomed | $3,987.95 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $2,727.74 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Pascal |
| Medtronic Vascular, INC. | $2,080.56 | 2019-2020 | |
| Medtronic, INC. | $1,504.87 | 2021-2025 | Avalus, Mosaic, Penditure |
| Abbott Laboratories | $789.99 | 2019-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $708.11 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atriclip Laa Exclusion System |
| Zimmer Biomet Holdings, INC. | $226.52 | 2021-2024 | Sternalock Blu System |
| Shockwave Medical, INC | $202.44 | 2021 | |
| Artivion, INC. | $190.59 | 2019-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical, Cryovalve Sg Pulmonary Human Heart Valve |
| Cardiva Medical, INC. | $190.59 | 2021-2025 | Savvywire |
| Terumo Cardiovascular Systems Corporation | $165.62 | 2019-2020 | |
| Bolton Medical INC | $147.43 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Getinge USA Sales, LLC | $131.99 | 2025 | Vasoview Hemopro 2 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $120.85 | 2024 | Repatha |
| Impulse Dynamics (USA) INC. | $84.98 | 2022 | |
| Arthrex, INC. | $82.03 | 2025 | |
| Livanova USA, INC. | $74.25 | 2020-2021 | |
| Pfizer INC. | $73.23 | 2023-2024 | |
| Boston Scientific Corporation | $39.92 | 2023 | Watchman Flx |
| Davol INC. | $29.33 | 2025 | Arista |
| Lsi Solutions INC | $21.38 | 2021 | |
| Kls-Martin L.P. | $20.14 | 2025 | |
| Puma Biotechnology, INC. | $17.24 | 2022 | |
| Scpharmaceuticals INC. | $13.74 | 2024 | |
| Ethicon US, LLC | $11.34 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.58 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.